SCS Ventures

Founded in 1990, Socosur Chem. is proud to act as a family-owned, Paris-based investment firm: SCS Ventures.

 

As entrepreneurs active in private equity since 2012, our Socosur Asset Management team understands the many challenges startups and early stage companies face. 

 

Our goal? Draw upon our varied expertise and advise future industry leaders through critical stages of company development. We specialize in international issues, biotech, pharma and veterinary tech, and particularly the in-silico NAM toxicological expertise ecosystem.

From ideas to companies, SCS Ventures invests in the future of toxicology

 

We seek to provide only responsible, hands-on approaches in order to create long-term value for our partners and the ecosystem around us.

 

Our team has helped startups to navigate through critical stages of company development with sound advice from similar situations we had to face in our past ventures. We provide private investment for companies up to a Series A stage

 

Previous projects include

  • GMP scale up operations for Clinical Trials and
  • Later stage industrialization steps and GMP internationalization strategy